Industry Briefs: Apr. 9, 2012 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Industry Briefs: Apr. 9, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.

Company News

American Regent has initiated a nationwide voluntary recall of cyanocobalamin injection, USP, 1000 mcg/mL, 1-mL vial, for the following lot numbers: 1662, 1679, and 1683, due to cracks in the vials. Read More

AnaptysBio has announced a partnership with Celgene to develop antibodies against multiple therapeutic targets. Read More

Haupt Pharma has launched cold-chain storage capabilities in Japan. Read More

MPI Research and has agreed to provide preclinical and clinical testing to Edge Therapeutics. Read More

Shimadzu Scientific Instruments and the University of Texas at Arlington have formed the Shimadzu Center for Advanced Analytical Chemistry. Read More

Spectrum Pharmaceuticals has agreed to acquire Allos Therapeutics. Read More

Univar has expanded its relationship with BASF Pharma by adding its Cognis Pharmaline range to its European pharmaceutical portfolio. Read More

People News

Bioanalytical Systems, Inc. (BASi) has named Jacqueline Lemke chief financial officer. Read More

Lonza has appointed Richard Ridinger as CEO. Read More


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here